BMC cancer

Frontiers in oncology

[1] A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.

[2] Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.

[3] epcam expression in colon adenocarcinoma and its relationship with tnm staging

[4] A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients.

[5] leiomyosarcoma as a second metachronous malignant neoplasm following colon adenocarcinoma. a case report and review of the literature

[6] Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma.

[7] epcam expression in colon adenocarcinoma and its relationship with tnm staging

[8] cucurbitacin l 2-o-β-glucoside demonstrates apoptogenesis in colon adenocarcinoma cells (ht-29): involvement of reactive oxygen and nitrogen species regulation

[9] down-regulation of mir-135b in colon adenocarcinoma induced by a tgf-β receptor i kinase inhibitor (sd-208)

[10] distant ureteral metastasis from colon adenocarcinoma: report of a case and review of the literature